Future Medicine

SHERPA: White

People

  1. Motzer
    Motzer
  2. Abou-Alfa
    Abou-Alfa
  3. Tap
    Tap
  4. Usmani
    Usmani
  5. Janjigian
    Janjigian
  6. Slovin
    Slovin
  7. Traina
    Traina
  8. Yu
    Yu
  9. Adusumilli
    Adusumilli
  10. Drilon
    Drilon

Groups

  1. Department of Medicine (120)
  2. Solid Tumor Oncology Division (96)
  3. Hematologic Malignancies, Division of (28)
  4. Surgery (26)
  5. Survivorship Research (24)
  6. Population Sciences Research Program (20)
  7. Gastrointestinal Oncology Service (19)
  8. Genitourinary Oncology Service (18)
  9. Thoracic Oncology (18)
  10. Center for Hematologic Malignancies (17)
Search Within
Formats
  1. Journal Article (152)
  2. Review (35)
  3. Editorial (9)
  4. Book Section (7)
  5. Book Whole (3)
  6. Correspondence (1)
Groups
  1. Department of Medicine (120)
  2. Solid Tumor Oncology Division (96)
  3. Hematologic Malignancies, Division of (28)
  4. Surgery (26)
  5. Survivorship Research (24)
  6. Population Sciences Research Program (20)

More Groups

People
  1. Robert Motzer (6)
  2. Yelena Janjigian (6)
  3. Ghassan Abou-Alfa (5)
  4. Saad Usmani (5)
  5. William Tap (5)
  6. Helena Yu (4)

More People

Years
  1. 2025 (15)
  2. 2024 (21)
  3. 2023 (19)
  4. 2022 (13)
  5. 2021 (18)
  6. 2020 (6)

More Years

Publications
  1. Future Oncology (124)
  2. Immunotherapy (22)
  3. Imaging in Medicine (5)
  4. Breast Cancer Management (4)
  5. Hodgkin and Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (4)
  6. Personalized Medicine (4)

More Publications

Results (207)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III MANIFEST-2: Pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis
    Review

    Harrison, C. N.; Gupta, V. K.; Gerds, A. T.; Rampal, R.; Verstovsek, S.; Talpaz, M.; Kiladjian, J. J.; Mesa, R.; Kuykendall, A. T.; Vannucchi, A. M.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancer
    Review

    Tsuboi, M.; Goldman, J. W.; Wu, Y. L.; Johnson, M. L.; Paz-Ares, L.; Yang, J. C. H.; Besse, B.; Su, W.; Chao, B. H.; Drilon, A.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Obinutuzumab in the treatment of B-cell malignancies: A comprehensive review
    Review

    Davies, A.; Kater, A. P.; Sharman, J. P.; Stilgenbauer, S.; Vitolo, U.; Klein, C.; Parreira, J.; Salles, G.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Patient preferences for treatment in relapsed/refractory diffuse large B-cell lymphoma: A discrete choice experiment
    Journal Article

    Birch, K.; Snider, J. T.; Chiu, K.; Baumgardner, J.; Wade, S. W.; Shah, G.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • MATTERHORN: Phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
    Review

    Janjigian, Y. Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Marcovitz, M.; Ruscica, D.; Robbins, S. H.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • PD-L1 expression and overall survival in Asian and western patients with gastric cancer
    Journal Article

    Rha, S. Y.; Ku, G. Y.; Kim, H. S.; Chung, H. C.; Amlashi, F. G.; Maru, D. M.; Fein, C. A.; Tang, L. H.; Zhou, W.; Wu, T.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden
    Journal Article

    Peterfy, C.; Chen, Y.; Countryman, P.; Chmielowski, B.; Anthony, S. P.; Healey, J. H.; Wainberg, Z. A.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Encorafenib plus binimetinib in patients with BRAF(V600)-mutant non-small cell lung cancer: Phase II PHAROS study design
    Journal Article

    Riely, G. J.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Smit, E. F.; Tsao, A. S.; Alcasid, A.; Usari, T.; Wissel, P. S.; Wilner, K. D.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Clinician perspectives on communication and implementation challenges in precision oncology
    Journal Article

    Hamilton, J. G.; Banerjee, S. C.; Carlsson, S. V.; Vera, J.; Lynch, K. A.; Sar-Graycar, L.; Martin, C. M.; Parker, P. A.; Hay, J. L.
    Personalized Medicine (2021)

    Fulltext@MSK | Save
  • Potential policy reforms to strengthen the accelerated approval pathway
    Journal Article

    Kaltenboeck, A.; Mehlman, A.; Pearson, S. D.
    Journal of Comparative Effectiveness Research (2021)

    Fulltext@MSK | Save

    • Future Medicine – authorized name for: